Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
8,845,328
-
Share change
-
+705,799
-
Total reported value
-
$72,793,000
-
Put/Call ratio
-
318%
-
Price per share
-
$8.23
-
Number of holders
-
40
-
Value change
-
+$5,188,802
-
Number of buys
-
22
-
Number of sells
-
17
Institutional Holders of TRACON PHARMACEUTICALS INC - COM NEW (TCON) as of Q1 2021
As of 31 Mar 2021,
TRACON PHARMACEUTICALS INC - COM NEW (TCON) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,845,328 shares.
The largest 10 holders included
Ikarian Capital, LLC, Opaleye Management Inc., VANGUARD GROUP INC, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, BOOTHBAY FUND MANAGEMENT, LLC, Linden Advisors LP, DEUTSCHE BANK AG\, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.